此页面上的内容需要较新版本的 Adobe Flash Player。

获取 Adobe Flash Player

Home > R&D > Achievements & awards

In 1996, the hypoglycemic drug glipizide and glipizide tablets were identified as state-level new product by the five ministries ,the NSTC(National Science and Technology Commission),ICBC( Industrial and Commercial Bank of China), the State Department of Labor, SAFEA(State Administration of Foreign Experts Affairs) and CSBTS( the State Bureau of Technical Supervision) .

In 2001, the urine test strips was identified as national key new product by the five ministries, the ministry of Science and Technology, State Administration of Taxation, MOFTEC (Ministry of Foreign Trade and Economic Cooperation), General Administration of Quality Supervision, Inspection and Quarantine and SEPA(State Environmental Protection Administration).

In 2001, flunarizine hydrochloride capsules’ research and development was included in the national Torch Program by the National Ministry of Science and Technology.

In 2002, Disha tablets’production and APIs’synthesis was funded by the Ministry of National Science and Technology Innovation Fund.

In 2004, itopride hydrochloride dispersible tablets’ research and development was included in the national Torch Program by the National Science and Technology.

In 2008, candesartan cilexetil tablets’ research and development was included in the national Torch Program by the National Ministry of Science and Technology.

Since 2000, "DISHA and the Design of disha" trademarks are recognized as "Shandong Famous Brand" four consecutive times.

The glipizide tablet of disha has been identified as "Shandong Famous Brand" products for many years.

 

In 2011, Disha Trademark was awarded Chinese Famous Brand.